Material Event Form 8 K

Item 8.01 Other Events.

On December 27, 2024, Lipella Pharmaceuticals Inc. (the "Company") reconvened the Company's special meeting of stockholders (the "Special Meeting") that was previously adjourned from December 20, 2024. After counting the number of shares present in person and by proxy at the Special Meeting, the chairman of the Special Meeting determined that a quorum for the transaction of business was not present. Accordingly, no action was taken with respect to the proposal presented at the Special Meeting, and the Special Meeting was cancelled.